/

EVLO

Evelo Biosciences, Inc.Closed

0.0002000.00 0.00%USD

OTC Markets OTCPK · as of Oct 12, 16:00 ET · 15m delay

Open

0.000500

Prev close

0.000200

Day range

0.0005000.000500

52-week range

0.0001000.000500

Volume

1330.05×

Mkt cap

3.80K

P/E ttm

—

Fwd P/E

-0.00

EPS ttm

-6.29

Div yield

0.00%

Earnings

—

From 52w high

−60.00%

Price Chart

Yahoo Finance · delayed

EVLOOct 12, 2026O 0.0002H 0.0002L 0.0002C 0.00020.0000 (0.00%)

SMA 500.0001
SMA 2000.0002

1Y change 0.00% since Oct 10, 2025 close538 bars loadedTimes in America/New_YorkDraw from the left toolbar · click a drawing to edit · right-click for alerts and export

EVLO Evelo Biosciences, Inc. · Last Guard Finance

DES

Key Statistics

Yahoo Finance

Performance

1 week: 0.00%
1 month: +100.00%
3 months: +100.00%
6 months: +100.00%
Year to date: −60.00%
1 year: 0.00%

Valuation & ownership

Market cap: 3.80K
Enterprise value: 16.69M
P/E (ttm): —
Forward P/E: -0.00
PEG ratio: —
Price / book: —
Price / sales (ttm): —
EV / EBITDA: -0.24
EPS (ttm): -6.29
EPS (forward): -1.85
Beta (5y monthly): -28.58
Dividend yield: 0.00%
Payout ratio: —
Shares outstanding: 18.98M
Float: 18.90M
Short % of float: 2.22%
Short ratio (days): 0.12
Held by insiders: 0.00%
Held by institutions: 0.00%
Avg volume (3m): 2.67K
50-day average: 0.000112
200-day average: 0.000171
52-week change: 0.00%
S&P 500 52-week: +17.03%

Technicals (daily)

RSI (14): overbought 99.4
vs 50-day SMA: +78.57%
vs 200-day SMA: +11.73%
50 / 200-day trend: ▼ 50 below 200
MACD vs signal: ▲ above
ATR (14) % of price: 2.54%
Realised vol (20d, ann.): 246.0%
From 52-week high: −60.00%
From 52-week low: +100.00%

ANR

Analyst Consensus

No analyst coverage for this instrument.

Financial Snapshot

Full statements →trailing twelve months

Revenue (ttm): —
Revenue growth (yoy): —
Earnings growth (yoy): —
Gross margin: 0.00%
Operating margin: 0.00%
Profit margin: 0.00%

DES

About Evelo Biosciences, Inc.

Yahoo Finance profile

Evelo Biosciences, Inc., a clinical-stage biotechnology company, focuses on discovering and developing oral medicines that act on immune cells in the small intestine with systemic effects. It is developing EDP1815, a whole-microbe product candidate, which has completed a Phase 2 trial for the treatment of psoriasis . The company is also developing EDP1867, a non-live pharmaceutical preparation for single strain of Veillonella parvula, which is in Phase 1b clinical trial; EDP2939, an investigational oral biologic for the potential treatment of inflammatory diseases; and EDP1908, a product candidate for oncology. Evelo Biosciences, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.

Sector: Healthcare
Industry: Biotechnology
Employees: 66
Headquarters: Cambridge, MA, United States
Officers: Mr. Craig R. Jalbert CIRA President, Secretary, Principal Executive, Financial and Accounting Officer & Director
Dr. Chun Zhang Ph.D. Chief Technical Operations & Quality Officer
Ms. Leslie Wardwell-Scott Ph.D. VP and Head of Corporate Development & Strategic Integration
Dr. Andrea Itano Ph.D. Head of Research

SEAS

Seasonality · EVLO

2018–2026 · monthly returns

Strongest month Feb +40.51%Weakest month Mar −28.98%Averages use completed years only. Past seasonality doesn't predict future returns.

Year	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec	Year
2026	-60.0	-50.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	100.0			−60.0%
2025	0.0	400.0	-80.0	0.0	-20.0	25.0	0.0	0.0	0.0	0.0	0.0	0.0	−0.0%
2024	-18.6	4.2	-13.6	10.0	-98.8	-83.3	0.0	0.0	0.0	200.0	66.7	0.0	−99.2%
2023	-35.4	-40.4	-70.9	-14.9	-11.2	19.0	222.2	-36.9	-40.7	-89.5	-2.7	-84.6	−99.8%
2022	-22.4	-33.7	8.5	-27.1	-15.0	0.5	0.0	3.8	-4.6	-2.4	2.5	-23.0	−73.5%
2021	45.2	-30.7	-12.1	22.9	2.1	2.4	-33.0	23.5	-38.1	25.7	-2.6	-29.6	−49.8%
2020	44.6	-13.8	-25.8	47.5	-21.1	12.1	-22.2	16.5	18.7	-24.7	29.2	135.7	+197.8%
2019	-31.0	-2.1	-9.0	4.8	-10.8	20.1	-32.0	-10.1	11.1	7.0	-30.9	-10.0	−68.8%
2018						-25.7	7.1	6.6	-9.6	-25.2	8.9	31.1	−18.1%

EVLO

Price Chart

Keyboard shortcuts & functions

Anywhere

Command line

Charts (click the chart first)

Function codes

EVLO

Price Chart

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

Financial Snapshot

About Evelo Biosciences, Inc.

Seasonality · EVLO

Insider Activity · EVLO

Congress Trades · EVLO

Investors Holding EVLO

Investors Holding EVLO

Congress Trades · EVLO

Insider Activity · EVLO

Seasonality · EVLO

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

Financial Snapshot

About Evelo Biosciences, Inc.

Earnings & Dividends

News